GlassScriptPhysician profile
Jacob H Nelson
NPI 1104267780
$1,193.88
in general payments reported to CMS, 2019-2025
28 companies · $62.22 in 2025
The $62.22 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $170 · 2021: $249 · 2022: $99.14 · 2023: $163 · 2024: $26.44 · 2025: $62.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $234.38 | 2019-2024 | Renasys Touch, Pico |
| Nevro Corp. | $165.57 | 2022-2023 | Senza |
| Dynasplint Systems INC. | $96.69 | 2021 | |
| Horizon Therapeutics Plc | $59.55 | 2019-2021 | |
| Orthofix Medical, INC. | $53.93 | 2024-2025 | Accelstim, Physio-Stim |
| Paratek Pharmaceuticals, INC. | $51.38 | 2021-2022 | |
| Djo, LLC | $49.04 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $45.23 | 2019 | |
| Sandoz INC. | $40.03 | 2019-2020 | |
| Celularity INC. | $29.00 | 2019 | |
| Depuy Synthes Sales INC. | $28.35 | 2019 | |
| Tactile Systems Technology INC | $27.85 | 2019-2020 | |
| Acell, INC. | $27.42 | 2019 | |
| Organogenesis INC. | $22.81 | 2022 | |
| Abbvie INC. | $22.55 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $22.00 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $21.93 | 2022 | |
| Stryker Corporation | $21.47 | 2025 | Ortholoc 2 Lapifuse |
| Bioventus LLC | $20.83 | 2019 | |
| Fidia Pharma USA INC. | $20.54 | 2019 | |
| Kci USA, INC. | $20.54 | 2022 | |
| Medtronic Vascular, INC. | $20.14 | 2019 | |
| Rikco International, LLC | $18.38 | 2019 | |
| Biotissue Holdings INC. | $18.24 | 2021 | |
| Orpyx Medical Technologies US INC. | $16.99 | 2023 | Orpyx Si |
| Arteriocyte Medical Systems, INC. | $16.93 | 2020 | |
| Zyla Life Sciences, INC. | $14.91 | 2019 | |
| Electronic Waveform Lab, INC. | $7.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.